The real question is when will Canntab be generating significant profit for shareholders? The best answer is we probably don't know at this stage.
There certainly appears to be a window of opportunity with state & federal politicians broadly supporting the rollout of mm products for sufferers of various medical ailments. Votes are a powerful motivator & there has been numerous heartfelt news segments, lobbying & general pressure from the public to cut the red tape & get these products to patients as fast as possible.
Will this lead to fast tracking of mm products not previously seen? Hopefully.
MCL have setup a team of experts to strategize & development their plan to roll out Canntab which is a good start.
We have access to BHC import license & storage facilities which is big step in the right direction.
Shareholders expecting huge revenue from Canntab in the very near term may be overreaching but it would not surprise me at all if it's not as long as some think either.
- Forums
- ASX - By Stock
- CGB
- hemp is our future!
hemp is our future!, page-24
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)